Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial
Emanuele Rando , Mercedes Delgado-Valverde , Josune Goikoetxea Aguirre , Laura Guio Carrión , María José Blanco Vidal , José Luis Barrios Andrés , María Teresa Pérez Rodríguez , Lucía Martínez Lamas , Francisco Arnaiz de las Revillas , Carlos Armiñanzas , Carlos Ruiz de Alegría-Puig , Patricia Jiménez Aguilar , María del Carmen Martínez-Rubio , Carmen Sáez-Béjar , Carmen de las Cuevas , Andrés Martín-Aspas , Fátima Galán , José Ramón Yuste , José Leiva-León , Germán Bou , Luis Eduardo López Cortés
{"title":"Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial","authors":"Emanuele Rando , Mercedes Delgado-Valverde , Josune Goikoetxea Aguirre , Laura Guio Carrión , María José Blanco Vidal , José Luis Barrios Andrés , María Teresa Pérez Rodríguez , Lucía Martínez Lamas , Francisco Arnaiz de las Revillas , Carlos Armiñanzas , Carlos Ruiz de Alegría-Puig , Patricia Jiménez Aguilar , María del Carmen Martínez-Rubio , Carmen Sáez-Béjar , Carmen de las Cuevas , Andrés Martín-Aspas , Fátima Galán , José Ramón Yuste , José Leiva-León , Germán Bou , Luis Eduardo López Cortés","doi":"10.1016/j.ijid.2025.107917","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>We investigated the effectiveness of early oral switch for treating Enterobacterales bloodstream infection (BSI) by performing a post hoc emulation trial of the SIMPLIFY trial.</div></div><div><h3>Methods</h3><div>We conducted a post hoc analysis of a randomized controlled trial. We specified the target trial characteristics selecting patients who achieved clinical stability on day 5. We categorized patients into those who switched on day 5 and those who continued intravenously. The primary outcome was clinical cure at the test of cure. We set a propensity score for being switched on day 5 to reduce confounding. We ran simple, not-propensity-adjusted, and propensity-adjusted logistic regression models to ascertain the association of switch on day 5 with clinical cure.</div></div><div><h3>Results</h3><div>Among 303 patients who achieved clinical stability on day 5, 110 (36.3%) were switched orally on day 5, and 193 (63.7%) were kept intravenously. We detected no difference in clinical cure between those switched on day 5 and those continued intravenously (risk ratios 1.04, 95% confidence intervals [CI] 0.98-1.10). Propensity-adjusted analysis did not show an association between day 5 switch and clinical cure (OR 2.10, 95% CI 0.96-7.41).</div></div><div><h3>Conclusion</h3><div>Oral step-down therapy on day 5 was not associated with worse clinical cure for Enterobacterales BSI.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"156 ","pages":"Article 107917"},"PeriodicalIF":4.8000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225001407","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
We investigated the effectiveness of early oral switch for treating Enterobacterales bloodstream infection (BSI) by performing a post hoc emulation trial of the SIMPLIFY trial.
Methods
We conducted a post hoc analysis of a randomized controlled trial. We specified the target trial characteristics selecting patients who achieved clinical stability on day 5. We categorized patients into those who switched on day 5 and those who continued intravenously. The primary outcome was clinical cure at the test of cure. We set a propensity score for being switched on day 5 to reduce confounding. We ran simple, not-propensity-adjusted, and propensity-adjusted logistic regression models to ascertain the association of switch on day 5 with clinical cure.
Results
Among 303 patients who achieved clinical stability on day 5, 110 (36.3%) were switched orally on day 5, and 193 (63.7%) were kept intravenously. We detected no difference in clinical cure between those switched on day 5 and those continued intravenously (risk ratios 1.04, 95% confidence intervals [CI] 0.98-1.10). Propensity-adjusted analysis did not show an association between day 5 switch and clinical cure (OR 2.10, 95% CI 0.96-7.41).
Conclusion
Oral step-down therapy on day 5 was not associated with worse clinical cure for Enterobacterales BSI.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.